Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2026-02-28 @ 3:47 AM
Study NCT ID:
NCT04152434
Status:
COMPLETED
Last Update Posted:
2019-11-05
First Post:
2019-10-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment of Chronic Migraine With Erenumab Alone or as an Add on Therapy
Sponsor:
Clinique des Céphalées de Montréal
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Erenumab 01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None